Crossmark

Discrimination of the S-isomer of ofloxacin using nanozyme-enhanced immunochromatographic analysis based on a secondary antibody-modified Au@Pd nanozyme

Crossref DOI link: https://doi.org/10.1007/s00604-026-08172-7

Published Online: 2026-06-08

Published Print: 2026-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hendrickson, Olga D.

Byzova, Nadezhda A.

Panferov, Vasily G.

Zvereva, Elena A.

Ivanova, Taisiya V.

Xing, Shen

Zherdev, Anatoly V.

Lei, Hongtao

Dzantiev, Boris B.
Funding

Funding for this research was provided by:

Russian Science Foundation (24-46-00026)
License Information

Text and Data Mining valid from 2026-06-08

Version of Record valid from 2026-06-08
More Information

Article History

Received: 27 March 2026

Accepted: 24 May 2026

First Online: 8 June 2026

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below